Clinical Trial Update: Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).

View source ↗

Summary

A completed clinical trial assessing the effectiveness of PAPILOCARE in regressing cervical HPV-related cytological abnormalities.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dysplasia
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• PAPILOCARE

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Papillomavirus Infections | Status: COMPLETED